How can DAOs - Decentralized Autonomous Organizations - improve rare disease research? Biorasi's Few & Far Between Podcast welcomes Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics and host of the Lady Scientist podcast, to discuss this new connection between clinical trials and cryptocurrency.
Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...
“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...
“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...